|
WO2021074357A1
|
|
Thiophene derivatives for use in treating portal inflammation and fibrosis
|
|
WO2021009331A1
|
|
Improved treatment using eyp001
|
|
WO2021009332A1
|
|
Method for decreasing adverse-effects of interferon
|
|
WO2021009333A1
|
|
Synergistic effect of eyp001 and ifn for the treatment of hbv infection
|
|
WO2020260526A1
|
|
Tertiary amine derivatives and their uses for treating a viral infection
|
|
US2021038566A1
|
|
Use of modulators of neet proteins for the treatment of infection
|
|
EP3749649A1
|
|
Non-fused thiophene derivatives and their uses
|
|
CA3087829A1
|
|
Fused thiophene derivatives and their uses
|
|
KR20190098204A
|
|
Thiophene Derivatives as Antiviral Agents
|
